Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trialStephen A. Boorjian, Colin P. Dinney, Jeffrey S. Montgomery et al.|The Lancet Oncology|2020Cited by 459
Renal AngiomyolipomaHakan Aydın, Ming Zhou, Cristina Magi‐Galluzzi et al.|The American Journal of Surgical Pathology|2009Cited by 253
Gleason 6 Prostate Cancer: Translating Biology into Population HealthScott E. Eggener, William T. Lowrance, Ketan K. Badani et al.|The Journal of Urology|2015Cited by 82
Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin–Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 TrialVikram M. Narayan, Colin P. Dinney, Stephen A. Boorjian et al.|The Journal of Urology|2024Cited by 80
Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific PropertiesLawrence N. Barrera, Eithne Costello, A.G. Evans et al.|Cancer Research|2020Cited by 27